We speculate that this could be due to the increased capacity of the CAFs to move and/or to bind to the TNBC cancer cells, for example, through adhesions between CAF N-cadherin and cancer cell E-cadherin [34], or by altered ECM deposition and remodeling [35,36,37]. The gene discussed is CDH2; the disease is cancer.